• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Relevium Technologies: Global Brands for the Nutraceutical and Wellness Markets

    Kevin Vanstone
    Apr. 24, 2019 03:41PM PST
    Pharmaceutical Investing
    FWB:6BX

    Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX) has launched its campaign on the Investing News Network’s cannabis channel.

    Relevium Technologies (TSXV:RLV,OTC:RLLVF;FWB:6BX) has launched its campaign on the Investing News Network’s cannabis channel.

    Relevium Technologies is developing a portfolio of brands, products and technologies in the health and wellness market. The company has assets in the United States and the United Kingdom with plans to expand into international markets including Canada and Latin America. The company is developing four brands which are offered through its two subsidiaries: BioGanix and Biocannabix. BioGanix is the parent company for a variety of weight-loss, health, beauty and fitness supplements. Together the brands under the BioGanix label generate over $1 million in revenue per quarter.

    Biocannabix aims to serve the pediatric and adult markets with nutraceutical and pharmaceutical cannabis-based products available in the United States and Europe. Relevium has launched LeefyLyfe, a hemp-based product line, to consumers in the UK under its Biocannabix brand. Biocannabix has secured a 93,000-square-foot organic cultivation and processing facility in Montreal, Quebec. Once complete, the facility is expected to be home to Relevium’s research and development facilities.

    Relevium Technologies’ company highlights include the following:

    • Global cannabis market to surpass $31 billion by 2021.
    • In 2017, the global wellness market reached $4.2 trillion.
    • Global nutraceutical market to reach US$578.23 billion by 2025.
    • Vast distribution network through industry giants like Walmart and Amazon.
    • Building out 93,000-square-foot cannabis cultivation and processing facility in Montreal, Quebec.
    • BioGanix generates approximately $1 million in revenue per quarter.
    • 47 SKUs developed for BioGanix to date.
    • Acquiring Cannakids’s IP, a leader in medical cannabis patient research and pediatric and adult consumer product development.
    • Pending Sleipnir acquisition will initially bring in US$500,000 to Relevium’s topline revenue.
    • Partnership in place with HempCo Canada.
    • International expansion plans for all brands.

    Click here to see the educational profile for Relevium Technologies and to request an investor presentation.

    pharmaceutical investingeuropefwb:6bxtsxv:rlv
    The Conversation (0)

    Go Deeper

    AI Powered
    Person touching a cannabis plant; Australia map in flag colours.

    ASX Cannabis Stocks: 10 Biggest Companies

    A colorful brain illustrating brain on pyschedelics.

    Psychedelics Stocks to Watch

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×